We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Canadian Court Blocks Generic Celebrex Launch

Law360 (May 1, 2007, 12:00 AM EDT) -- A Canadian appeals court has upheld patents for painkiller Celebrex that prevent the launch of a generic version of the drug until November 2014, Pfizer Inc. said Tuesday.

The Federal Court of Appeal of Canada reversed a lower court ruling that permitted Teva Pharmaceuticals’ Canadian subsidiary Novopharm from launching its version of Celebrex. The appellate court’s order prohibits regulatory approval of a generic Celebrex until Pfizer’s patents regarding the drug’s compound expire in 2014.

“Without appropriate protection of intellectual property, Pfizer and other research-based pharmaceutical companies...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.